Literature DB >> 11487506

Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanism.

L de Garavilla1, N Vergnolle, S H Young, H Ennes, M Steinhoff, V S Ossovskaya, M R D'Andrea, E A Mayer, J L Wallace, M D Hollenberg, P Andrade-Gordon, N W Bunnett.   

Abstract

Thrombin, generated in the circulation during injury, cleaves proteinase-activated receptor 1 (PAR1) to stimulate plasma extravasation and granulocyte infiltration. However, the mechanism of thrombin-induced inflammation in intact tissues is unknown. We hypothesized that thrombin cleaves PAR1 on sensory nerves to release substance P (SP), which interacts with the neurokinin 1 receptor (NK1R) on endothelial cells to cause plasma extravasation. PAR1 was detected in small diameter neurons known to contain SP in rat dorsal root ganglia by immunohistochemistry and in situ hybridization. Thrombin and the PAR1 agonist TFLLR-NH(2) (TF-NH(2)) increased [Ca(2+)](i) >50% of cultured neurons (EC(50)s 24 mu ml(-1) and 1.9 microM, respectively), assessed using Fura-2 AM. The PAR1 agonist completely desensitized responses to thrombin, indicating that thrombin stimulates neurons through PAR1. Injection of TF-NH(2) into the rat paw stimulated a marked and sustained oedema. An NK1R antagonist and ablation of sensory nerves with capsaicin inhibited oedema by 44% at 1 h and completely by 5 h. In wild-type but not PAR1(-/-) mice, TF-NH(2) stimulated Evans blue extravasation in the bladder, oesophagus, stomach, intestine and pancreas by 2 - 8 fold. Extravasation in the bladder, oesophagus and stomach was abolished by an NK1R antagonist. Thus, thrombin cleaves PAR1 on primary spinal afferent neurons to release SP, which activates the NK1R on endothelial cells to stimulate gap formation, extravasation of plasma proteins, and oedema. In intact tissues, neurogenic mechanisms are predominantly responsible for PAR1-induced oedema.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11487506      PMCID: PMC1572861          DOI: 10.1038/sj.bjp.0704152

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  44 in total

Review 1.  Protease-activated receptors: sentries for inflammation?

Authors:  T M Cocks; J D Moffatt
Journal:  Trends Pharmacol Sci       Date:  2000-03       Impact factor: 14.819

2.  Localization of protease-activated receptors-1 and -2 in human mast cells: indications for an amplified mast cell degranulation cascade.

Authors:  M R D'Andrea; C J Rogahn; P Andrade-Gordon
Journal:  Biotech Histochem       Date:  2000-03       Impact factor: 1.718

3.  Intestinal type 2 proteinase-activated receptors: expression in opioid-sensitive secretomotor neural circuits that mediate epithelial ion transport.

Authors:  B T Green; N W Bunnett; A Kulkarni-Narla; M Steinhoff; D R Brown
Journal:  J Pharmacol Exp Ther       Date:  2000-10       Impact factor: 4.030

4.  Altered vascular injury responses in mice deficient in protease-activated receptor-1.

Authors:  W M Cheung; M R D'Andrea; P Andrade-Gordon; B P Damiano
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-12       Impact factor: 8.311

5.  Evaluation of proteinase-activated receptor-1 (PAR1) agonists and antagonists using a cultured cell receptor desensitization assay: activation of PAR2 by PAR1-targeted ligands.

Authors:  A Kawabata; M Saifeddine; B Al-Ani; L Leblond; M D Hollenberg
Journal:  J Pharmacol Exp Ther       Date:  1999-01       Impact factor: 4.030

6.  The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations.

Authors:  F Striggow; M Riek; J Breder; P Henrich-Noack; K G Reymann; G Reiser
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

7.  Expression of protease-activated receptor-2 during embryonic development.

Authors:  A L Jenkins; C Chinni; M R De Niese; B Blackhart; E J Mackie
Journal:  Dev Dyn       Date:  2000-07       Impact factor: 3.780

8.  Presence and bronchomotor activity of protease-activated receptor-2 in guinea pig airways.

Authors:  F L Ricciardolo; M Steinhoff; S Amadesi; R Guerrini; M Tognetto; M Trevisani; C Creminon; C Bertrand; N W Bunnett; L M Fabbri; S Salvadori; P Geppetti
Journal:  Am J Respir Crit Care Med       Date:  2000-05       Impact factor: 21.405

9.  Motor neuron cell death in wobbler mutant mice follows overexpression of the G-protein-coupled, protease-activated receptor for thrombin.

Authors:  B W Festoff; M R D'Andrea; B A Citron; R M Salcedo; I V Smirnova; P Andrade-Gordon
Journal:  Mol Med       Date:  2000-05       Impact factor: 6.354

Review 10.  Inflammation-coagulation network: are serine protease receptors the knot?

Authors:  G Cirino; C Napoli; M Bucci; C Cicala
Journal:  Trends Pharmacol Sci       Date:  2000-05       Impact factor: 14.819

View more
  40 in total

1.  Neutrophil Elastase Activates Protease-activated Receptor-2 (PAR2) and Transient Receptor Potential Vanilloid 4 (TRPV4) to Cause Inflammation and Pain.

Authors:  Peishen Zhao; TinaMarie Lieu; Nicholas Barlow; Silvia Sostegni; Silke Haerteis; Christoph Korbmacher; Wolfgang Liedtke; Nestor N Jimenez-Vargas; Stephen J Vanner; Nigel W Bunnett
Journal:  J Biol Chem       Date:  2015-04-15       Impact factor: 5.157

Review 2.  Protease-activated receptors: regulation of neuronal function.

Authors:  Toshiyuki Saito; Nigel W Bunnett
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 3.  Proteinase-activated receptors in the lower urinary tract.

Authors:  James D Moffatt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-02-10       Impact factor: 3.000

Review 4.  New insights into protease-activated receptor 4 signaling pathways in the pathogenesis of inflammation and neuropathic pain: a literature review.

Authors:  Yanju Bao; Yebo Gao; Liping Yang; Xiangying Kong; Honggang Zheng; Wei Hou; Baojin Hua
Journal:  Channels (Austin)       Date:  2015       Impact factor: 2.581

5.  Protease-activated receptors as therapeutic targets in visceral pain.

Authors:  Nicolas Cenac
Journal:  Curr Neuropharmacol       Date:  2013-12       Impact factor: 7.363

6.  Parkin mediates beclin-dependent autophagic clearance of defective mitochondria and ubiquitinated Abeta in AD models.

Authors:  Preeti J Khandelwal; Alexander M Herman; Hyang-Sook Hoe; G William Rebeck; Charbel E-H Moussa
Journal:  Hum Mol Genet       Date:  2011-03-04       Impact factor: 6.150

7.  Neutrophils and the kallikrein-kinin system in proteinase-activated receptor 4-mediated inflammation in rodents.

Authors:  Steeve Houle; Martin D Papez; Mara Ferazzini; Morley D Hollenberg; Nathalie Vergnolle
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

8.  Protease activated receptors in cardiovascular function and disease.

Authors:  Junor A Barnes; Shamjeet Singh; Aldrin V Gomes
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

Review 9.  Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems.

Authors:  Kristina K Hansen; Katerina Oikonomopoulou; Yang Li; Morley D Hollenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-10-19       Impact factor: 3.000

10.  Protease activated receptors 1 and 4 sensitize TRPV1 in nociceptive neurones.

Authors:  Vittorio Vellani; Anna M Kinsey; Massimiliano Prandini; Sabine C Hechtfischer; Peter Reeh; Pier C Magherini; Chiara Giacomoni; Peter A McNaughton
Journal:  Mol Pain       Date:  2010-09-27       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.